![Paul Averback](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 4 M $ in data 30/06/2025
Paul Averback is the founder of Nymox Pharmaceutical Corp.
since 1995, holding the title of Co-Chairman, President & Chief Executive Officer.
Former job includes President at DMS Pharmaceutical Group, Inc. Education includes a doctorate from the University of Cambridge, conferred in 1975.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 19/04/2025 | 35.008.010 ( 37,43% ) | 4 M $ | 30/06/2025 |
| Società | Posizione | Inizio |
|---|---|---|
| NYMOX PHARMACEUTICAL CORPORATION | Amministratore Delegato | 30/09/1995 |
| Società | Posizione | Fine |
|---|---|---|
DMS Pharmaceutical Group, Inc.
 DMS Pharmaceutical Group, Inc. Medical DistributorsDistribution Services Supplies pharmaceutical products | Presidente | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Nymox Pharmaceutical Corp.
 Nymox Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which specializes in the research and development of products for the aging population | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DMS Pharmaceutical Group, Inc.
DMS Pharmaceutical Group, Inc. Medical DistributorsDistribution Services Supplies pharmaceutical products | Distribution Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
